- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02845505
Intravascular Ultrasound Prediction of Myocardial Size and Coronary Computed Tomography-Derived Ischemic Burden for Coronary Lesion (IVUS-CAMS)
December 11, 2023 updated by: Young-Hak Kim, MD, PhD, Asan Medical Center
The aims of this study are 1) to identify IVUS determinants of the CAMS-derived myocardial territories subtended to the diseased vessels, 2) to find IVUS determinant for the extent of CAMS-derived myocardial size, and 3) to develop the mathematical model that integrates the IVUS information about myocardial territory and stenosis severity and predicts the extent of CAMS-derived myocardial size.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Anyang, Korea, Republic of
- Hallym University Sacred Heart Hospital
-
Daejeon, Korea, Republic of
- Chungnam National University Hospital
-
Gangneung, Korea, Republic of
- Gangneung Asan Hospital
-
Gyeonggi-do, Korea, Republic of
- Hallym University Dongtan Sacred Heart Hospital
-
Pusan, Korea, Republic of
- Pusan National University Hospital
-
Pusan, Korea, Republic of
- Inje University Pusan Paik Hospital
-
Pusan, Korea, Republic of
- Kosin University Gospel Hospital
-
Seoul, Korea, Republic of
- Kangbuk Samsung Hospital
-
Seoul, Korea, Republic of
- Veterans Hospital Medical Center
-
Ulsan, Korea, Republic of
- Ulsan University Hospital
-
Yangsan, Korea, Republic of
- Pusan National University Yangsan Hospital
-
-
Songpa-Gu
-
Seoul, Songpa-Gu, Korea, Republic of
- Asan Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
patients who undergo coronary computed tomography angiography, invasive coronary angiography and IVUS assessment prior to intervention will be enrolled.
The patients should have at least one coronary artery lesion (including non-left main and isolated left main disease) with visually estimated diameter stenosis >50%
Description
Inclusion Criteria:
- Age 20years or older
- Patients who have at least one epicardial coronary artery lesion (including isolated left main disease or side branch) with visually estimated diameter stenosis >50% and take coronary angiography, CT angiography and IVUS
- Willing and able to provide informed written consent
Exclusion Criteria:
- In-stent restenosis
- Bypass graft
- Suspected coronary spasm even after sufficient nitrate injected
- Cases in which the IVUS imaging catheter failed to cross the lesion
- Poor quality IVUS or CT images
- Visible collateral flow on angiography
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
IVUS-CAMS
patients who undergo coronary computed tomography angiography, invasive coronary angiography and IVUS
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
mathematically-predicted ischemic size (by using IVUS parameters) vs. CAMS-derived myocardial size subtended to the stenotic segment
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Impact of plaque characteristics (attenuated plaque, plaque rupture, calcification, thrombosis, etc.) assessed by IVUS on the ischemic burden assessed by CAMS
Time Frame: 1 year
|
1 year
|
Incidence of MACE comprising death, nonfatal myocardial infarction or target vessel revascularization
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 22, 2016
Primary Completion (Actual)
April 22, 2022
Study Completion (Estimated)
June 30, 2024
Study Registration Dates
First Submitted
July 13, 2016
First Submitted That Met QC Criteria
July 24, 2016
First Posted (Estimated)
July 27, 2016
Study Record Updates
Last Update Posted (Estimated)
December 13, 2023
Last Update Submitted That Met QC Criteria
December 11, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AMCCV 2016-06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Intravascular Ultrasound, coronary computed tomography angiography
-
Central Clinical Hospital of the Russian Academy...Ural State Medical University; De Haar Research Task Force; De Haar Research... and other collaboratorsTerminatedCoronary Artery Disease | Alzheimer Disease | Contrast-induced Nephropathy | Coronary Atherosclerosis | Cerebrovascular Disease | Stable Chronic Angina | Chronic Coronary InsufficiencyNetherlands, Russian Federation, Estonia
-
University of AarhusDanish Heart Foundation; Danish Research Agency; Philips Medical SystemsCompletedAtherosclerosisDenmark
-
Shanghai Zhongshan HospitalNot yet recruitingCoronary Artery Disease | Left Main Coronary Artery Disease
-
Seoul National University Bundang HospitalCompletedDiabetes Mellitus | Coronary AtherosclerosisKorea, Republic of
-
Abbott Medical DevicesCardiovascular Research Foundation, New YorkCompletedCoronary Artery DiseaseUnited States, Spain, Japan, United Kingdom, Germany, Belgium, Italy, Netherlands
-
National University of Ireland, Galway, IrelandGE Healthcare; HeartFlow, Inc.RecruitingMyocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive DiseasesItaly, Belgium, Germany
-
Erasmus Medical CenterRecruitingCoronary Artery DiseaseNetherlands
-
UMC UtrechtUnknownPostoperative Myocardial Injury
-
University of EdinburghNHS Lothian; NHS Greater Glasgow and Clyde; University of Glasgow; Chief Scientist...RecruitingCardiovascular Diseases | Kidney Transplant; ComplicationsUnited Kingdom
-
Rennes University HospitalCompleted